Submitted by Anonymous (not verified) on 17 April 2024 - 15:03
Human medicines European public assessment report (EPAR): Xolair, omalizumab, Date of authorisation: 25/10/2005, Revision: 50, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Xolair, omalizumab, Date of authorisation: 25/10/2005, Revision: 50, Status: Authorised